Emergent BioSolutions Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 20, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	487	500	113	551	2,056	3,882
Market Cap Growth	-13.90%	344.13%	-79.56%	-73.19%	-47.03%	56.42%
Enterprise Value	848	1,008	829	1,323	2,483	4,296
Last Close Price	9.19	7.63	2.22	11.04	40.12	76.00
PE Ratio	7.53	-	-	-	10.65	15.53
PS Ratio	0.72	0.50	0.12	0.53	1.32	3.01
PB Ratio	0.98	1.07	0.19	0.43	1.45	3.28
P/TBV Ratio	4.40	-	1.51	1.34	2.99	9.18
P/FCF Ratio	408.35	14.47	-	-	24.34	12.02
P/OCF Ratio	43.98	8.82	-	-	7.30	8.85
EV/Sales Ratio	1.27	1.00	0.87	1.26	1.59	3.33
EV/EBITDA Ratio	4.54	19.55	-	90.08	5.60	8.63
EV/EBIT Ratio	8.07	-	-	-	7.32	10.53
EV/FCF Ratio	711.03	29.17	-	-	29.39	13.30
Debt / Equity Ratio	1.15	1.40	1.35	1.03	0.54	0.64
Debt / EBITDA Ratio	3.05	12.66	-	90.85	1.72	1.50
Debt / FCF Ratio	479.29	18.89	-	-	9.13	2.34
Net Debt / Equity Ratio	0.73	1.19	1.18	0.56	0.19	0.21
Net Debt / EBITDA Ratio	1.93	10.80	-16.29	49.38	0.60	0.50
Net Debt / FCF Ratio	303.93	16.11	-2.97	-5.17	3.13	0.76
Asset Turnover	0.54	0.65	0.42	0.37	0.61	0.61
Inventory Turnover	1.19	2.29	2.34	2.38	3.01	2.70
Quick Ratio	2.89	1.56	0.47	0.66	2.29	2.22
Current Ratio	5.77	3.69	1.04	0.99	3.40	3.11
Return on Equity (ROE)	13.91%	-33.67%	-74.67%	-14.11%	14.35%	24.12%
Return on Assets (ROA)	5.27%	-2.03%	-4.21%	-2.23%	8.26%	11.98%
Return on Invested Capital (ROIC)	9.09%	-4.22%	-9.40%	-5.36%	15.27%	21.13%
Return on Capital Employed (ROCE)	9.40%	-4.30%	-14.30%	-5.60%	14.90%	20.00%
Earnings Yield	13.28%	-36.80%	-610.73%	-35.91%	9.39%	6.44%
FCF Yield	0.24%	6.91%	-207.11%	-25.44%	4.11%	8.32%
Buyback Yield / Dilution	-6.86%	-3.52%	-2.20%	7.39%	-0.56%	-2.67%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.